Point72 Asset Management, L.P. 13D and 13G filings for Alto Neuroscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:11 pm Sale | 2026-03-31 | 13G | ALTO NEUROSCIENCE INC ANRO | Point72 Asset Management, L.P. | 1,170,865 3.700% | -1,653,410 (-58.54%) | Filing |
| 2026-02-17 4:30 pm Purchase | 2025-12-31 | 13G | ALTO NEUROSCIENCE INC ANRO | Point72 Asset Management, L.P. | 2,824,275 8.900% | 916,444 (+48.04%) | Filing |
| 2025-05-15 4:26 pm Sale | 2025-03-31 | 13G | ALTO NEUROSCIENCE INC ANRO | Point72 Asset Management, L.P. | 1,907,831 7.000% | -452,100 (-19.16%) | Filing |
| 2025-02-14 4:05 pm Purchase | 2024-12-31 | 13G | ALTO NEUROSCIENCE INC ANRO | Point72 Asset Management, L.P. | 2,359,931 8.800% | 667,153 (+39.41%) | Filing |
| 2024-02-07 4:25 pm Purchase | 2024-02-06 | 13G | ALTO NEUROSCIENCE INC ANRO | Point72 Asset Management, L.P. | 1,692,778 6.300% | 1,692,778 (New Position) | Filing |